[go: up one dir, main page]

AR036310A1 - Un sistema de suministro - Google Patents

Un sistema de suministro

Info

Publication number
AR036310A1
AR036310A1 ARP020103244A ARP020103244A AR036310A1 AR 036310 A1 AR036310 A1 AR 036310A1 AR P020103244 A ARP020103244 A AR P020103244A AR P020103244 A ARP020103244 A AR P020103244A AR 036310 A1 AR036310 A1 AR 036310A1
Authority
AR
Argentina
Prior art keywords
elastomer composition
core
membrane
poly
different
Prior art date
Application number
ARP020103244A
Other languages
English (en)
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of AR036310A1 publication Critical patent/AR036310A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un sistema de suministro que comprende un núcleo y una membrana que encapsula dicho núcleo, en donde dicho núcleo y dicha membrana consisten esencialmente de una composición de elastómero igual o diferente, en donde dicho núcleo comprende al menos dos agentes terapéuticamente activos, cada uno de los cuales tiene una velocidad de liberación. La membrana puede consistir en al menos dos capas, cuyo grosor puede ser diferente y comprende además un espacio que separa al menos en dos las partes del núcleo. Dicha membrana de separación consiste esencialmente de una composición de elastómero, siendo la membrana de separación permeable o impermeable a al menos uno de los agentes terapéuticamente activos. La composición de elastómero se selecciona del grupo que consiste en: una composición de elastómero que comprende poli(dimetilsiloxano); una composición de elastómero que comprende un elastómero con base de siloxano que comprende grupos 3,3,3-trifluoropropilo unidos a los átomos de Si de las unidades siloxano; una composición de elastómero que comprende grupos poli(óxido de alquileno), en donde dichos grupos poli(óxido de alquileno) están presentes como injertos terminados con alcoxi o bloques unidos a las unidades de polisiloxano mediante enlaces de silicio-carbono, o como una mezcla de estas formas; y una combinación de al menos dos de los mismos. Las velocidades de liberación de los al menos dos agentes terapéuticos activos son idénticas o diferentes. El sistema de suministro puede ser un implante, un sistema intrauterino, un sistema intracervical o un sistema intravaginal, y el agente terapéuticamente activo puede ser una hormona.
ARP020103244A 2001-08-31 2002-08-29 Un sistema de suministro AR036310A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31597201P 2001-08-31 2001-08-31

Publications (1)

Publication Number Publication Date
AR036310A1 true AR036310A1 (es) 2004-08-25

Family

ID=23226904

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103244A AR036310A1 (es) 2001-08-31 2002-08-29 Un sistema de suministro

Country Status (14)

Country Link
US (1) US20040247674A1 (es)
EP (1) EP1427390A1 (es)
JP (1) JP2005503389A (es)
KR (1) KR20040036928A (es)
CN (1) CN1289064C (es)
AR (1) AR036310A1 (es)
AU (1) AU2002313517B2 (es)
CA (1) CA2457979A1 (es)
HU (1) HUP0401438A3 (es)
NO (1) NO20041315L (es)
PE (1) PE20030316A1 (es)
PL (1) PL367961A1 (es)
RU (1) RU2302883C2 (es)
WO (1) WO2003017971A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US20040181943A1 (en) * 2003-03-18 2004-09-23 Michael Kwiecien Shaving systems
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
AU2004258894B2 (en) * 2003-07-17 2010-06-03 Patheon Softgels Inc. Controlled release preparations
ES2561463T3 (es) * 2003-08-21 2016-02-26 Addbio Ab Dispositivo de implante recubierto con bisfosfonato y método para el mismo
US20060105017A1 (en) * 2004-06-22 2006-05-18 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
PL1629844T5 (pl) 2004-07-13 2012-10-31 Bayer Schering Pharma Oy Długoterminowy system dostarczania leku z kontrolowanym początkowym wyrzutem
US7494665B1 (en) 2004-07-30 2009-02-24 Advanced Cardiovascular Systems, Inc. Polymers containing siloxane monomers
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2007109247A2 (en) * 2006-03-20 2007-09-27 Duramed Pharmaceuticals, Inc. Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
RU2342125C1 (ru) * 2007-04-27 2008-12-27 Александр Сергеевич Бабиков Способ введения анестетика в ткани
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
EP2057972A1 (en) * 2007-11-07 2009-05-13 N.V. Organon Intrauterine deposit
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
PL2062569T3 (pl) * 2007-11-22 2011-10-31 Bayer Oy Dopochwowy układ dostarczania leku
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
DE102008006416A1 (de) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
KR20140048321A (ko) * 2008-02-04 2014-04-23 테바 위민즈 헬스 인코포레이티드 프로게스테론 함유 단일형 질내 링 및 그의 제조방법과 용도
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
AU2009294545B2 (en) 2008-09-17 2014-07-10 Bayer Oy An inserter
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
SI2381932T1 (sl) * 2009-01-29 2018-12-31 Fondazione Irccs Instituto Nazionale Dei Tumori Naprava za v maternični vrat za sproščanje zdravil za lokalno regionalno zdravljenje raka materničnega vratu
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102525722A (zh) * 2010-12-30 2012-07-04 辽宁爱母医疗科技有限公司 具有记忆效应的智能型复方孕二烯酮阴道环制剂及其应用
EP2476409A1 (en) * 2011-01-14 2012-07-18 Université Catholique De Louvain Implant comprising a core and a tube encasing the core
WO2012138542A1 (en) * 2011-04-07 2012-10-11 Arstat, Inc. Treatment of menstrual pain and excessive menstrual blood loss by intravaginal administration of a low dose of antifibrinolytic or hemostatic agent in combination with non- steroidal anti-inflammatory drug
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
DE102012024126A1 (de) 2011-12-20 2013-06-20 Merck Patent Gmbh Flüssigkristallines Medium
AR089765A1 (es) 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
EP2953678B1 (en) * 2013-02-06 2020-03-25 Sillender, Mark Therapeutic substance transfer catheter
AU2014214538B2 (en) 2013-02-06 2018-11-15 Mark SILLENDER Embryo transfer catheter and method
SE539540C2 (sv) * 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
US9963556B2 (en) 2013-09-18 2018-05-08 Senseonics, Incorporated Critical point drying of hydrogels in analyte sensors
KR20160072114A (ko) * 2013-10-18 2016-06-22 베이어 오와이 자궁내 전달 시스템
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10772842B2 (en) * 2015-01-09 2020-09-15 Patheon Softgels Inc. Abuse-deterrent opioids
EP3148494A4 (en) * 2014-05-30 2017-12-20 Textile-Based Delivery, Inc. Drug delivery systems and related methods of use
HUE046267T2 (hu) 2015-01-21 2020-02-28 Bayer Oy Nem szteroid gyulladáscsökkentõ (NSAID) és progesztogén vegyületet tartalmazó gyógyszerbeviteli rendszer és elõállítási eljárások
US11096888B2 (en) 2015-05-13 2021-08-24 Bayer Oy Long acting drug delivery device and its use in contraception
CN105056376A (zh) * 2015-08-21 2015-11-18 崔尚品 一种治疗宫颈炎和宫颈hpv感染的医疗器械
WO2019094625A1 (en) * 2017-11-09 2019-05-16 Nexien Biopharma, Inc. Methods and compositions for parenteral administration of cannabidiol in the treatment of convulsive disorders
WO2019119059A1 (en) * 2017-12-22 2019-06-27 Alyra Biotech Pty Ltd Treatment of pain and/or pain related symptoms associated with dysmenorrhea
CN110917478B (zh) * 2019-12-10 2020-11-24 河南省肿瘤医院 一种宫颈hpv感染用药物缓释器
US11173291B2 (en) * 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) * 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) * 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
WO2022029780A1 (en) * 2020-08-06 2022-02-10 Bless Medical Ltd. Intrauterine device for controlled drug release
US20230047191A1 (en) * 2021-08-05 2023-02-16 Celanese Eva Performance Polymers Llc Implantable Medical Device for the Delivery of Bisphosphonate

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
US5443461A (en) * 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
JP2002511075A (ja) * 1997-06-04 2002-04-09 デビオ ルシェルシュ ファルマスティク ソシエテ アノニム 薬学的活性成分の制御放出のためのインプラント及びその製造方法
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females

Also Published As

Publication number Publication date
JP2005503389A (ja) 2005-02-03
HUP0401438A3 (en) 2008-04-28
CA2457979A1 (en) 2003-03-06
PE20030316A1 (es) 2003-04-03
US20040247674A1 (en) 2004-12-09
EP1427390A1 (en) 2004-06-16
CN1289064C (zh) 2006-12-13
KR20040036928A (ko) 2004-05-03
HUP0401438A2 (hu) 2004-11-29
RU2302883C2 (ru) 2007-07-20
NO20041315L (no) 2004-03-30
PL367961A1 (en) 2005-03-07
CN1549703A (zh) 2004-11-24
WO2003017971A1 (en) 2003-03-06
AU2002313517B2 (en) 2007-09-06
RU2004109575A (ru) 2005-08-20

Similar Documents

Publication Publication Date Title
AR036310A1 (es) Un sistema de suministro
AR026647A1 (es) Dispositivo para el suministro de farmacos que tienen propiedades antiprogestinicas
RU2226387C2 (ru) Устройство для доставки лекарственных средств, особенно для доставки прогестинов и эстрогенов
DE60023520D1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
ES2081531T3 (es) Composiciones farmaceuticas que contienen rifaximina para el tratamiento de infecciones vaginales.
WO2004064912A8 (en) An otorhinological delivery device
PE20100057A1 (es) Sistema de suministro intrauterino para la liberacion controlada de progestageno
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
ATE276758T1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
RU2001116107A (ru) Устройство для доставки лекарственных средств, особенно для доставки прогестинов и эстрогенов
PE20001019A1 (es) Nueva membrana o matriz para controlar la penetracion de farmacos
AR046485A1 (es) Sistema de administracion para drogas y terapia celular
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
ATE461681T1 (de) Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
AR018952A1 (es) Una membrana o matriz para controlar la velocidad de penetracion de farmacos
CO5540373A2 (es) Composicion farmaceutica de liberacion sostenida
ES2194232T3 (es) Reservorio de espuma polimerica para dispositivo de aporte por electrotransporte.
BR0007360A (pt) Composição de liberação controlada
RU2001116118A (ru) Устройство для доставки лекарственного средства, особенно для доставки андрогенов
JP2018516889A5 (es)
ES2201794T3 (es) Dispositivo de administracion de farmacos, espcialmente para la administracion de androgenos.
BRPI0509053A (pt) composição farmacêutica anidra e uso de um agente siliconado e de uma composição
DE60035672D1 (de) Biologisch abbaubaren keramischen fasern aus kiselsäuresol
ES2383418T3 (es) Agente celular antiangiogénico para la terapia del cáncer.

Legal Events

Date Code Title Description
FB Suspension of granting procedure